Cutera, Inc. Stock price

Equities

CUTR

US2321091082

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 11:09:55 2024-03-28 am EDT 5-day change 1st Jan Change
1.47 USD +5.76% Intraday chart for Cutera, Inc. -36.09% -58.30%
Sales 2023 212M Sales 2024 * 163M Capitalization 27.75M
Net income 2023 -151M Net income 2024 * -131M EV / Sales 2023 0.33 x
Net cash position 2023 * - Net cash position 2024 * - EV / Sales 2024 * 0.17 x
P/E ratio 2023
-0.46 x
P/E ratio 2024 *
-0.26 x
Employees 540
Yield 2023 *
-
Yield 2024 *
-
Free-Float 95.01%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.42%
1 week-34.12%
Current month-37.95%
1 month-47.35%
3 months-60.17%
6 months-77.44%
Current year-60.57%
More quotes
1 week
1.28
Extreme 1.2804
2.01
1 month
1.28
Extreme 1.2804
2.46
Current year
1.28
Extreme 1.2804
4.97
1 year
1.28
Extreme 1.2804
27.16
3 years
1.28
Extreme 1.2804
74.38
5 years
1.28
Extreme 1.2804
74.38
10 years
1.28
Extreme 1.2804
74.38
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 23-05-18
Director of Finance/CFO 58 21-06-30
Chief Tech/Sci/R&D Officer 61 19-09-30
Members of the board TitleAgeSince
Director/Board Member 68 21-05-16
Director/Board Member 66 -
Chief Executive Officer 48 23-05-18
More insiders
Date Price Change Volume
24-03-28 1.47 +5.76% 501 483
24-03-27 1.39 -1.42% 1,111,013
24-03-26 1.41 -1.40% 980,430
24-03-25 1.43 -10.63% 2,107,241
24-03-22 1.6 -30.43% 4,153,528

Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT

More quotes
Cutera, Inc. is a provider of aesthetic and dermatology solutions for practitioners. The Company develops, manufactures, distributes, and markets energy-based product platforms for use by physicians and other practitioners, enabling them to offer aesthetic treatments to their customers. The Company offers easy-to-use products based on the product platforms, such as enlighten, enlighten SR, excel HR, excel V, excel V+, truSculpt iD, truSculpt flex, Secret PRO, Secret RF, and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures, including treatment for body contouring, skin resurfacing and revitalization, tattoo removal, removal of benign pigmented lesions, vascular conditions, hair removal, and toenail fungus. Its platforms allow for the delivery of laser light and/or RF energy for aesthetic applications from a single system. It also offers products, such as ProWave 770, AcuTip 500, Titan XL, LimeLight, Pearl, Pearl Fractional and ProWave LX.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
1.39 USD
Average target price
6.333 USD
Spread / Average Target
+355.64%
Consensus
  1. Stock
  2. Equities
  3. Stock Cutera, Inc. - Nasdaq